Omeros reported $38.5M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.69M 0.66M
Adma Biologics ADMA:US $ 28.07M 3.5M
Aerie Pharmaceuticals AERI:US $ 119.66M 4.37M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Cytokinetics CYTK:US $ 66.84M 0M
Dynavax Technologies DVAX:US $ 345.2M 121M
Gilead Sciences GILD:US $ 9220M 662M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Insmed INSM:US $ 113.82M 11.43M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Knight Therapeutics Inc GUD:CN C$ 126.03M 4.72M
Macrogenics MGNX:US $ 50.88M 16.22M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Omeros OMER:US $ 38.5M 3.44M
Pacira Pharmaceuticals PCRX:US $ 133.18M 171.89M
Regulus Therapeutics RGLS:US $ 5.83M 1.13M
Rockwell Medical RMTI:US $ 18.54M 1.06M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
Vital Therapies VTL:US $ 10.4M 1.06M
Xoma XOMA:US $ 8.42M 534K